A potential new procedure for removing anti-factor VIII antibodies from hemophilic plasma. 1987

V Regnault, and C Rivat, and J P Vallet, and C Francois-Gerard, and G Brochier, and J P Allain

A new approach for removing the anti-factor VIII antibodies in hemophilic patients by immunoadsorption is proposed. The method is based on the fact that the anti-factor VIII antibodies were predominantly of the IgG4 subclass; anti-human IgG4 antibodies were covalently linked to agarose and large amounts of anti-factor VIII antibodies can be eliminated. A study of 21 blood samples from hemophilic patients with anti-factor VIII antibodies allows us to confirm the large predominance of IgG4 in the anti-factor VIII population. In some samples, the presence of IgG3 related anti-VIII:C was checked by adsorption on an anti-IgG3 column. In a majority of cases, after IgG4 (or IgG4 + IgG3) immunoadsorption, the substitution therapy becomes possible or easier.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007163 Immunosorbent Techniques Techniques for removal by adsorption and subsequent elution of a specific antibody or antigen using an immunosorbent containing the homologous antigen or antibody. Immunoadsorbent Techniques,Immunoadsorbent Technics,Immunosorbent Technics,Immunoadsorbent Technic,Immunoadsorbent Technique,Immunosorbent Technic,Immunosorbent Technique,Technic, Immunoadsorbent,Technic, Immunosorbent,Technics, Immunoadsorbent,Technics, Immunosorbent,Technique, Immunoadsorbent,Technique, Immunosorbent,Techniques, Immunoadsorbent,Techniques, Immunosorbent
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D012685 Sepharose Agarose,Sepharose 4B,Sepharose C1 4B,4B, Sepharose C1,C1 4B, Sepharose

Related Publications

V Regnault, and C Rivat, and J P Vallet, and C Francois-Gerard, and G Brochier, and J P Allain
October 1970, Journal of chronic diseases,
V Regnault, and C Rivat, and J P Vallet, and C Francois-Gerard, and G Brochier, and J P Allain
May 1992, Proceedings of the National Academy of Sciences of the United States of America,
V Regnault, and C Rivat, and J P Vallet, and C Francois-Gerard, and G Brochier, and J P Allain
April 1988, Proceedings of the National Academy of Sciences of the United States of America,
V Regnault, and C Rivat, and J P Vallet, and C Francois-Gerard, and G Brochier, and J P Allain
January 1972, Pathologie-biologie,
V Regnault, and C Rivat, and J P Vallet, and C Francois-Gerard, and G Brochier, and J P Allain
May 1977, The Journal of clinical investigation,
V Regnault, and C Rivat, and J P Vallet, and C Francois-Gerard, and G Brochier, and J P Allain
March 2009, Blood,
V Regnault, and C Rivat, and J P Vallet, and C Francois-Gerard, and G Brochier, and J P Allain
June 1978, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
V Regnault, and C Rivat, and J P Vallet, and C Francois-Gerard, and G Brochier, and J P Allain
December 1977, The New England journal of medicine,
V Regnault, and C Rivat, and J P Vallet, and C Francois-Gerard, and G Brochier, and J P Allain
October 2005, Thrombosis and haemostasis,
V Regnault, and C Rivat, and J P Vallet, and C Francois-Gerard, and G Brochier, and J P Allain
September 1988, British journal of haematology,
Copied contents to your clipboard!